id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1991-N-0311-0003,FDA,FDA-1991-N-0311,Tab A Federal Register Vol. 58 No. 84 pgs 26652-26655 re: Comment from Abbott Laboratories,Supporting & Related Material,Background Material,2017-07-11T04:00:00Z,2017,7,,,2017-07-11T14:19:04Z,,0,0,090000648290d988
FDA-1991-N-0311-0001,FDA,FDA-1991-N-0311,"Antibiotic Drugs; Clarithromycin, Clarithromycin Tablets",Rule,Final Rule,2017-07-11T04:00:00Z,2017,7,1993-05-04T04:00:00Z,1993-06-04T03:59:59Z,2017-07-11T14:10:05Z,93-10311,0,0,090000648052fd96
FDA-1991-N-0311-0004,FDA,FDA-1991-N-0311,Tab B Clarithromycin Assay Linearity re: Comment from Abbott Laboratories,Supporting & Related Material,Background Material,2017-07-11T04:00:00Z,2017,7,,,2017-07-11T14:20:55Z,,0,0,090000648290d989